# Role of Active Deresuscitation After Resuscitation:

> **NCT06326112** · PHASE2 · UNKNOWN · sponsor: **Unity Health Toronto** · enrollment: 120 (estimated)

## Conditions studied

- Fluid Overload
- Critical Illness
- Sepsis
- ARDS
- Trauma

## Interventions

- **DRUG:** Furosemide Injection
- **DRUG:** Metolazone Tablets

## Key facts

- **NCT ID:** NCT06326112
- **Lead sponsor:** Unity Health Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-05-01
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-06-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-03-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06326112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06326112, "Role of Active Deresuscitation After Resuscitation:". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06326112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*